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Sambuceti, Gianmario, Mario Marzilli, Andrea Mari,
Cecilia Marini, Paolo Marzullo, Roberto Testa, Isa-
bella Raugei, Micaela Papini, Mathis Schluter, and
Antonio L’Abbate. Clinical evidence for myocardial dere-
cruitment downstream from severe stenosis: pressure-flow
control interaction. Am J Physiol Heart Circ Physiol 279:
H2641–H2648, 2000.—To verify the interaction between cor-
onary pressure (CP) and blood flow (CBF) control, we studied
nine candidates for angioplasty of an isolated lesion of the
left anterior descending coronary artery [i.e., percutaneous
transluminal coronary angioplasty (PTCA)]. CBF (i.e., flow
velocity 3 coronary cross-sectional area at the Doppler tip)
and CP were monitored during washout of 2–5 mCi of 133Xe
after bolus injection into the left main artery before and after
PTCA. Xe mean transit time (MTT) was calculated as the
area under the time-activity curve, acquired by a gamma
camera, divided by the dose obtained from a model fit of the
Xe curve in the anterior wall. CBF response to intracoronary
adenosine (2 mg) was also assessed. PTCA increased baseline
CBF (from 14.5 6 9.4 to 20 6 8 ml/min, P , 0.01), coronary
flow reserve (from 1.52 6 0.24 to 2.33 6 0.8, P , 0.01), and
CP (from 64 6 9 to 100 6 10 mmHg, P , 0.05). MTT
decreased from 89 6 32 to 70 6 19 s (P , 0.05) after PTCA;
however, MTT and CBF changes were not correlated (r 5
20.09, not significant). Inasmuch as MTT is the ratio of
distribution volume to CBF, MTT 3 CBF was used as an
index of perfused myocardial volume. Volume increased after
PTCA from 23 6 18 to 56 6 30 ml. A direct correlation was
observed between the percent increase in distal CP and
percent increase in perfused volume (r 5 0.91, P , 0.01).
Thus low CP was not associated with exhaustion of flow
reserve but, rather, with reduction of perfused myocardial
volume. These data suggest that, in the presence of a severe
coronary stenosis, derecruitment of vascular units occurs
that is proportional to the decrease in driving pressure.
Residual perfused units maintain a vasomotor tone, thus
explaining the paradoxical persistence of coronary reserve.
coronary circulation; microcirculation; coronary angioplasty;
autoregulation; coronary artery disease
MYOCARDIAL METABOLISM IS STRICTLY aerobic; because of
the high oxygen extraction under baseline conditions,
increases in oxygen consumption can only be met by
corresponding increases in coronary blood flow (6, 37).
According to this concept, it is generally assumed that
myocardial metabolism is the primary factor control-
ling microvascular tone and that ischemia implies a
maximal vasodilation of coronary microvasculature or
exhaustion of coronary flow reserve. However, several
experimental studies reported the persistence of a sig-
nificant vasodilator reserve in moderately ischemic
myocardium (2, 7, 8, 32) and, even more, the occur-
rence of a microvascular constriction during acute se-
vere ischemia (17, 20). The mechanisms underlying
these phenomena have not been conclusively identi-
fied, although they have been attributed to anesthesia
(9), an active downregulation of myocardial metabo-
lism below the actual flow availability (7), or a primary
microvascular constriction (10). Although this behavior
seems paradoxical when the autoregulation of coro-
nary circulation and myogenic reflex are considered, it
agrees with observations obtained in peripheral and
coronary microcirculation during hemorrhagic shock
(21, 31) and suggests that further mechanisms, besides
oxygen demand, affect vasomotor tone in is-
chemic myocardium.
The most frequent cause of resting hypoperfusion in
humans is the presence of a coronary stenosis. In this
setting, a direct correlation exists between coronary
blood flow and transstenotic pressure gradient; thus,
since resting aortic pressure can be considered rela-
tively constant, an inverse correlation exists between
coronary blood flow and distal coronary pressure (18,
19). Several data indicate that the vascular tree, and in
particular the microvascular network, is controlled to
maintain an adequate pressure at the capillary level to
provide correct exchanges between blood and intersti-
tium (42). In the presence of a very severe stenosis, the
flow demand might imply an excessive pressure gradi-
ent and, thus, an excessively low coronary pressure.
Such a vasoconstrictor response to reduced pressure
might represent a mechanism able to maintain a cor-
rect pressure in the perfused vascular units, provided
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that it might act to exclude myocardial units as paral-
lel resistors from perfusion.
The recent introduction of manometer-tipped wires,
together with Doppler monitoring of blood flow, allows
the measurement of microvascular coronary resistance
in patients with coronary artery disease. When coupled
with the analysis of the washout of a freely diffusible
tracer and applied to the clinical model of coronary
angioplasty, this technology permits the study of coro-
nary blood flow and perfused myocardial volume at
different coronary pressures under stable systemic he-
modynamics. This possibility is crucial, since the sta-
bility of aortic pressure minimizes the triggering of
reflexes that might directly affect coronary vasomotor
tone. We used this experimental setting to estimate the
interrelationship between coronary pressure, blood
flow, and myocardial volume.
MATERIALS AND METHODS
Study population. Nine candidates for coronary angio-
plasty (mean age 61 6 3 yr) were included according to the
following criteria: 1) history of stable angina, 2) electrocar-
diographic (ECG) evidence of exercise-induced ischemia, 3)
single-vessel disease of the left anterior descending coronary
artery, 4) no previous myocardial infarction, 5) left main
stem longer than 2 cm, 6) no angiographic evidence of collat-
eral circulation, 7) absence of arterial hypertension and/or
left ventricular hypertrophy, and 8) no diabetes.
Study protocol. Patients were studied after overnight fast,
under active treatment with oral diltiazem (60 mg 3 times/
day), isosorbide mononitrate (20 mg 3 times/day), and aspi-
rin. An 8.0-F guiding catheter was advanced into the left
main coronary artery, a control angiography was performed,
and the best projection was selected. Heparin (10,000 IU)
was injected intravenously; isosorbide dinitrate (0.6 mg) was
administered into the heart. A 0.014-in. fiber-optic pressure-
monitoring guide wire (Radi Medical, Uppsala, Sweden) was
calibrated and positioned distal to the stenosis (34). Finally,
a 2.5-F Doppler-tipped catheter (Millar Instruments, Hous-
ton, TX) was placed in the prestenotic segment, and a coro-
nary angiography was again obtained to measure cross-sec-
tional area at the tip of the Doppler catheter. Care was taken
to avoid side branching between the catheter tip and the
stenosis and to maintain the catheter in the center of the
lumen to obtain a stable flow-velocity signal.
A small field-of-view mobile gamma camera (model F1,
Elscint, Haifa, Israel) was brought to the catheterization
room. The system was equipped with a low-energy, high-
sensitivity parallel-hole collimator and was oriented on the
patient’s chest in a 70° left anterior oblique projection.
Stable blood flow and hemodynamics were verified for $5
min before baseline recordings. Thereafter, a bolus of 2–4
mCi of 133Xe was rapidly injected through the guiding cath-
eter soon after initiation of a dynamic acquisition set accord-
ing to the following parameters: energy window centered on
the photo peak of 133Xe and one frame every 2 s for 180 s. At
the end of acquisition, a bolus of adenosine (2 mg) was
selectively injected into the left anterior descending coronary
artery through the Doppler catheter.
The following signals were continuously monitored: 1) four
ECG leads (I, II, III, and V4), 2) phasic and mean aortic
pressure, 3) phasic and mean distal coronary pressure, and 4)
phasic and mean coronary blood flow velocity. Paper record-
ings (2.5 cm/s) were obtained at baseline and 30 s after
intracoronary adenosine. Distal coronary pressure was also
measured during balloon coronary occlusion.
After completion of this protocol, the Doppler catheter was
removed, and all patients underwent coronary angioplasty.
After revascularization, the Doppler catheter was advanced
in the treated vessel, and the protocol was repeated as before
angioplasty.
Data analysis. Stenosis severity (percent lumen area re-
duction) and vessel diameter at the tip of the Doppler cath-
eter were measured using an automated edge detection sys-
tem (Mipron, Kontron). Coronary blood flow index was
obtained by multiplying mean blood flow velocity by cross-
sectional area at the site of the Doppler transducer, as pre-
viously described (16).
Mean transit time of Xe was calculated according to the
residue detection method. Original images were grouped into
20-s frames to allow a better definition of the left ventricular
walls. Two regions of interest were drawn on the anterior and
posterolateral wall, and frames were displayed in cine mode
to verify a stable geometry. Thereafter, the computer was
asked to plot the time-activity curves in stenotic-anterior and
control-posterolateral regions using the original 2-s frames.
The mean transit time was calculated, according to the
stochastic analysis, from the tracer residue curves as the
ratio of the area under the curve from zero to infinity to the
dose entering the region (44). These two values were esti-
mated using the model described below.
The tracer mass balance in the region of interest is
q 5 fin 2 fout (1)
where q is the tracer mass in the region, which is propor-
tional to the Xe radioactivity, fin is influx, and fout is efflux.
For the influx, the following representation was used
fin~t! 5 DG~u!~m/u!
utu21e2~u/m!t (2)
where D is the tracer dose entering the region (the integral
from zero to infinity of fin), G is the gamma function, m is the
mean transit time of fin, which is related to the delay of the
tracer appearance into the region, and u quantifies the dis-
persion of the dose around its mean transit time m. Equation
2, with only three parameters, ensures a flexible description
of the input function, which starts from zero, rapidly reaches
a peak, and returns to zero. Equation 2 is actually equivalent
to fin 5 at
be2ct, where a, b, and c are the parameters, but the
more complex expression is used because the parameters
have a clear meaning.
The efflux is represented as the convolution of the influx
and the transit time density function of the region. The
transit time density function, p(t), was modeled as the con-
volution of a single-exponential function with a two-exponen-
tial function. This gives p(t) the characteristics of a typical
efflux curve, which rapidly rises to a peak and decays with a
biphasic pattern. The expression used for p(t) is
p~t! 5 be2bt # @wa1e
2a1t 1 ~1 2 w!a2e
2a2t# (3)
where V is the convolution operator. The parameter b deter-
mines the initial rising of p(t), a1 and a2 are the exponents of
the biphasic decay, and w represents the relative contribu-
tion of the first exponential term of the decay.
By combining Eqs. 1–3, the differential equation describ-
ing the tracer residue curves is obtained. This equation was
solved using inversion of Laplace transforms, inasmuch as
Eqs. 1–3 can be conveniently handled in the domain of
Laplace transforms. Inversion of Laplace transforms was
performed with the algorithm of de Hoog et al. (12). The
parameters of Eqs. 1 and 2 were estimated by least-squares
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fit of the tracer residue curves. Calculations were performed
using the language of technical computing MatLab (the rou-
tine for the inversion of Laplace transforms was kindly pro-
vided by Karl Hollenbeck, Dept. of Hydrodynamics and Wa-
ter Resources, Technical University of Denmark, Lyngby,
Denmark).
The mean transit time in the region (calculated as area/
dose) is equal to the mean transit time of p(t), which is
obtained from the parameters of Eq. 3. Thus, although the
model provides an estimate of the input function (Eq. 2) and
of the transit time density function of the region (Eq. 3), it is
in practice only used for estimating the dose and for extrap-
olating the tail of the residue curve beyond the observation
window.
Mean transit time of a diffusible tracer is the ratio of the
distribution volume of the tracer to the flow crossing that
volume. When 133Xe is injected into the left main coronary
artery, such a formulation can be written as follows
MTT 5 V/CBF (4)
where MTT is the mean transit time, V is the distribution
volume of Xe, and CBF is the blood flow in the labeled
volume. Accordingly, the distribution volume of Xe, which is
an index of the perfused myocardium, was computed by
rearranging Eq. 4 as follows
V 5 MTT p CBF (5)
Statistical analysis. Values are means 6 SD. ANOVA,
followed by Newman-Keuls procedure for multiple compari-
sons and repeated measures, was used in each population to
identify significant changes in blood flow indexes at the
various stages of the protocol before or after angioplasty.
Linear regression analysis was performed by least-squares
method. P , 0.05 was considered significant.
RESULTS
Clinical and hemodynamic findings. No serious side
effects occurred during the study. Left ventriculogra-
phy showed mild to moderate anterior hypokinesis in
three of nine patients; left ventricular ejection fraction
was 0.56 6 0.04. Left ventricular end-diastolic pres-
sure was 9 6 4 mmHg. Coronary angioplasty was
successful in all patients and was optimized by a stent
deployment in seven of nine patients. Percent arterial
area reduction decreased from 96 6 4 to 14 6 6% (P ,
0.01). After revascularization, there were no signifi-
cant changes in heart rate or systolic or diastolic aortic
pressure (Table 1).
Coronary pressure and Doppler blood flow index.
Baseline blood flow index was 14.5 6 9.4 ml/min and
increased in all patients to 152 6 24% (range 115–
200%, P , 0.02) after adenosine. Transstenotic pres-
sure gradient was 27 6 14 mmHg at baseline, in-
creased to 37 6 15 mmHg after adenosine (P , 0.01),
and virtually disappeared after revascularization at
rest (2 6 2 mmHg) and after adenosine (5 6 4 mmHg,
P , 0.01 vs. corresponding values before revascular-
ization). Mean distal pressure was 64 6 9 mmHg at
baseline, decreased to 54 6 10 mmHg after adenosine
(P , 0.01 vs. baseline), and markedly (P , 0.01) in-
creased after angioplasty at rest (100 6 10 mmHg) and
after adenosine (99 6 9 mmHg; Table 1). During bal-
loon coronary occlusion, coronary wedge pressure was
19 6 7 mmHg.
Angioplasty increased (P , 0.01) blood flow index to
20 6 8 ml/min, corresponding to 180 6 93% of baseline
(Figs. 1 and 2). Similarly, a large increase was ob-
served in maximal flow capacity, which increased from
152 6 24 to 324 6 242% (P , 0.01) of preangioplasty
baseline flow, and coronary flow reserve, which in-
creased from 1.52 6 0.24 to 2.33 6 0.8 (P , 0.01).
Xe washout analysis. Background activity, before
postpercutaneous transluminal coronary angioplasty
study, was virtually absent in all cases, resulting in
,1% of peak activity after tracer injection. Similarly,
heart-to-background ratio was .4 at the end of all
studies. Fitting of the Xe washout curve was possible in
all cases. The model residuals, i.e., the differences
between the measured and model-predicted Xe radio-
activity, indicated that the model fit was acceptable. In
the majority of the time points from 0 to 180 s (81% of
the points), the mean residuals were within 2 SE for
the point, indicating no bias. Although in a significant
proportion of the time points (19%) the mean residuals
differed from zero by .2 SE, the value was ,1% of the
peak value, and the mean residuals exhibited small
oscillations but not a tendency to under- or overesti-
mate the slope of the tracer curves. These results
indicate that the model extrapolation of the tail of the
tracer curve was adequate. The model-estimated dose
entering the regions of interest was 113 6 1.3% (SE) of
the measured Xe peak (all 18 curves pooled). This
result is consistent with the notion that a small frac-
tion of the tracer dose (13% in our calculation) leaves
the region of interest before the peak value is reached.
Mean transit time of Xe washout was 89 6 32 s at
baseline and decreased to 70 6 19 s (76 6 21%, P ,
0.05) after angioplasty. In the contralateral region, this
variable similarly decreased from 94 6 34 to 68 6 24 s
(P , 0.05). Thus mean transit time was similar in the
stenotic and remote myocardium before and after re-
Table 1. Hemodynamic data before and after revascularization
Before Angioplasty After Angioplasty
Baseline Intracoronary adenosine Baseline Intracoronary adenosine
Heart rate, beats/min 70610 73610 7068 7269
Mean aortic pressure, mmHg 97615 101610 10069 10469
Mean coronary pressure, mmHg 6469 54610* 100610*† 9969*†
Values are means 6 SD. Heart rate and aortic pressure did not change throughout the study. *P , 0.05 vs. baseline before percutaneous
transluminal coronary angioplasty (PTCA); †P , 0.05 vs. intracoronary adenosine before PTCA.
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vascularization. No correlation was observed between
the increase in coronary blood flow and the decrease in
mean transit time of Xe induced by revascularization
(r 5 0.19, not significant; Fig. 3).
The volume of distribution of Xe, derived by Doppler
coronary blood flow 3 mean transit time, increased
from 23 6 18 to 56 6 30 ml (P , 0.05) after revascu-
larization; this phenomenon showed a large variation
between patients (Fig. 4); however, a close direct cor-
relation was observed between the increase in driving
coronary pressure and the increase in volume of distri-
bution of the tracer (r 5 0.91, P , 0.01; Fig. 5). No
correlation was observed between changes in perfused
myocardial volume and coronary wedge pressure mea-
sured during balloon coronary occlusion (r 5 0.13, not
significant).
DISCUSSION
In the present study, angioplasty of severe coronary
artery stenosis was associated with a marked increase
in absolute coronary blood flow and coronary flow re-
serve assessed by intracoronary Doppler catheter.
However, the increase in resting coronary blood flow
was markedly larger than (and not correlated with) the
decrease in mean transit time of 133Xe, indicating a
significant increase in the volume of distribution of the
tracer and, thus, in the mass of perfused myocardium
after revascularization. Moreover, a significant corre-
lation was observed between the increase in the per-
fused volume and the increase in distal coronary pres-
sure. These findings suggest that, in the presence of a
very severe stenosis and transstenotic pressure gradi-
ent, observed resting coronary blood flow is distributed
to only a portion of the vascular units that are perfused
in the absence of the stenosis, i.e., after revasculariza-
tion. The spatial and temporal distribution of the per-
fused units, within the jeopardized region, cannot be
identified from the present study.
Coronary angioplasty and coronary blood flow. An-
gioplasty markedly increased Doppler coronary blood
Fig. 1. Coronary angiography (top), pressure and
flow velocity traces (middle), and Xe washout curves
(bottom) at rest and before and after percutaneous
transluminal coronary angioplasty (PTCA). PTCA
abolished epicardial stenosis and increased distal
coronary pressure (dCP) to values similar to aortic
pressure (AoP) at rest and after intracoronary aden-
osine. Adenosine significantly increased coronary
blood flow velocity (CBFV) before and after PTCA.
Balloon coronary occlusion markedly decreased
dCP. PTCA markedly increased coronary blood flow
at rest and after adenosine. Nevertheless, Xe wash-
out curve did not change after revascularization in
the jeopardized area (solid line) and remained sim-
ilar to the washout curve observed in the remote
region (dashed line). Thus the increase in flow in-
duced by PTCA was not associated with a marked
increase in Xe mean transit time. ECG, electrocar-
diogram.
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flow index in all patients. Such a phenomenon might
reflect the occurrence of postocclusion reactive hyper-
emia (39) or the presence of a significant hypoperfusion
before vessel recanalization. After revascularization,
adenosine markedly increased coronary blood flow, re-
vealing the presence of a significant coronary flow
reserve. In agreement with previous studies (4, 33, 40),
this observation strongly suggests a chronic hypoper-
fusion in myocardial regions exposed to a reduced driv-
ing pressure due to the presence of a severe stenosis.
However, Xe mean transit time was remarkably simi-
lar in the myocardium supplied by the stenotic artery
and in the remote region before and after angioplasty,
despite the marked increase in flow to the revascular-
ized myocardium. Since, according to tracer kinetic
theory, Xe mean transit time is the ratio of flow to
tracer distribution volume (23, 30, 44), this observation
would imply a similar increase in blood flow to both
regions or an increase in the distribution volume in the
revascularized myocardium. Coronary blood flow in the
nonstenotic coronary artery was not measured. How-
ever, heart rate and systolic aortic pressure remained
unchanged, and thus, in agreement with previous
studies, an increase in blood flow in this region, beyond
the modest increase in flow compatible with the in-
crease in Xe washout rate, seems unlikely (33). By
contrast, at least two observations suggest that the
volume of distribution of Xe in the revascularized area
was actually increased by angioplasty: the increase in
flow was higher than (and not correlated with) the
decrease in mean transit time, and the increase in
tracer distribution volume was directly correlated with
the increase in driving coronary pressure. The volume
of distribution of Xe reflects two main factors: the
so-called partition coefficient (related to the chemical
tissue constituents) (11) and the perfused myocardial
mass (related to the mass of the myocardium reached
by the tracer and thus by flow) (23, 30). Since dramatic
changes in the chemical components of the revascular-
Fig. 3. Relationship between changes in absolute CBF (blood flow
velocity 3 cross-sectional area of the coronary artery) and changes in
specific myocardial blood flow [inverse of Xe mean transit time
(MTT)]. In a homogeneously perfused system with a constant vol-
ume, a linear direct correlation should be observed between these 2
variables. The lack of this observation suggests an effect of revascu-
larization on the distribution volume of the tracer.
Fig. 4. Effect of PTCA on perfused myocardial volume (CBF 3 Xe
MTT) before and after PTCA.
Fig. 2. A: changes in absolute coronary blood flow (CBF) (blood flow velocity 3 cross-sectional area of the coronary
artery) induced by PTCA. B: effect of PTCA on specific flow (flow per unit mass) as measured by the inverse of Xe
mean transit time (MTT). The increase in absolute flow was higher than the increase in specific myocardial flow.
H2645SEVERE STENOSIS CAUSES MYOCARDIAL TISSUE DERECRUITMENT
 o
n
 M
ay 5, 2012
ajpheart.physiology.org
D
ow
nloaded from
 
ized myocardium are unlikely to occur in such a short
period of time, it seems reasonable to hypothesize an
increase in perfused myocardial mass. Thus these find-
ings strongly suggest a relationship between driving
coronary pressure and amount of the perfused myocar-
dium in patients with coronary artery disease.
Relationship between metabolic control of blood flow
and vascular control of pressure. An increase in flow
heterogeneity during ischemia has been described pre-
viously (13, 31, 41, 43, 45). This phenomenon has been
frequently explained by a heterogeneous distribution
of extravascular compressing forces or by the structure
of the coronary tree (3, 24). Actually, it is well known
that such a difference might explain the relative reduc-
tion in subendocardial flow during maximal vasodila-
tion, which has been documented in regions supplied
by a severely stenotic vessel or at low pressure (22, 24).
However, in the present study, resting hypoperfusion
was not associated with an exhausted vasodilator re-
serve, inasmuch as adenosine increased flow across the
coronary microcirculation, despite a reduced distal cor-
onary pressure, indicating the persistence of a residual
microcirculatory vasomotor tone. In line with this find-
ing, several authors documented vasodilator reserve in
the hypoperfused myocardium (2, 7, 8, 19, 32), and,
more recently, we observed even an active, severe va-
soconstriction of coronary microvasculature during un-
stable angina (29) and ischemia induced by atrial pac-
ing tachycardia (38). This mismatch between
myocardial metabolism and microvascular resistance
behavior might appear paradoxical when myocardial
metabolism is assumed to be the primary determinant
of vasomotor tone regulation. However, one should also
consider the relevance of pressure-driven control,
which avoids the notion that changes in aortic pressure
are directly brought at the capillary level with the
obvious dramatic consequence of altered plasma-inter-
stitial water and solute exchanges (26, 42). The myo-
genic reflex, which is the most acknowledged mecha-
nism in coronary autoregulation, could operate such a
control (5, 15). In patients with coronary artery dis-
ease, it seems conceivable that the putative vasodila-
tion required to match oxygen demand with blood flow
would imply an excessive pressure drop across a severe
stenosis (19). Since resting aortic pressure can be con-
sidered relatively stable, the pressure gradient would
result in an excessively low capillary pressure, thus
hampering the Starling forces (26, 42). Under these
conditions, the only mechanisms able to preserve cap-
illary pressure would be a venous constriction or the
exclusion of perfused units in a parallel circuit model.
In the present study, perfused myocardial volume in-
creased after revascularization, and this increase was
directly correlated with the increase in driving coro-
nary pressure. This observation suggests that the
transstenotic pressure gradient caused a reduction in
perfused myocardium and a “derecruitment” of vascu-
lar units from perfusion. These data do not elucidate
whether this is an all-or-none phenomenon nor do they
verify whether the exclusion of any given vascular unit
is continuous or intermittent. However, in agreement
with data by Chilian and Layne (10), these findings
suggest that the coronary microvasculature reacts to a
markedly reduced pressure by an active vasoconstric-
tion. Such a response leads to exclusion of myocardial
tissue from perfusion and thus to restoration of ade-
quate flow rates and microvascular pressures in the
perfused units. Such a mechanism might be even more
powerful than the effects of myocardial metabolism on
overall microvascular resistance. This concept closely
agrees with the experimental evidence of a recruitment
in perfused myocardial tissue in response to increases
in coronary pressure (25) under autoregulation and
during maximal vasodilation. Similarly, this model
might also help explain the marked heterogeneity of
blood flow, coronary reserve, and metabolic indexes of
ischemia, which has been observed in the experimental
setting (1, 13, 21, 27, 31, 41, 45).
Clinical implications. In patients with coronary ar-
tery disease, myocardial dysfunction is often observed
in regions subtended by severely stenotic coronary
arteries. In several instances, a contractile recovery
can be observed after revascularization (4). Since this
phenomenon has important prognostic implications,
its mechanisms have been extensively investigated. It
has not been fully defined whether regional dysfunc-
tion is the effect of chronic hypoperfusion (myocardial
hibernation) (35) or prolonged dysfunction after repet-
itive ischemia (myocardial stunning) (28). On the one
hand, studies evaluating myocardial perfusion by the
delivery or uptake of tracers, such as microspheres,
201Tl-Sestamibi, or [13N]ammonia, documented resting
perfusion defects in viable myocardial regions (4). In
contrast, this finding has been rarely reported by
positron emission tomography studies of myocardial
blood flow with radioactive water as a flow tracer (28).
Similarly, although the former techniques often re-
ported an increase in blood flow to revascularized ar-
eas, water studies of blood flow showed a smaller effect
of revascularization on resting myocardial blood flow.
These puzzling discordances might reflect the different
kinetics between diffusible tracers (which estimate
blood flow washout rates) and deposit tracers (which
estimate blood flow by the amount of tracer delivered)
(14, 23, 43). In the present study, mean transit time of
Xe was not markedly reduced in the “ischemic” region,
Fig. 5. Relationship between changes in coronary pressure and
changes in perfused myocardial volume (CBF 3 Xe MTT) induced by
revascularization (PTCA). A close direct correlation was observed
between these 2 variables, indicating an effect of driving coronary
pressure on the mass of myocardium perfused.
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indicating a near-to-normal specific flow in the per-
fused myocardium. In agreement with this finding, Xe
mean transit time did not markedly decrease after
revascularization However, the mass of the perfused
myocardium was reduced, since it markedly increased
after the restoration of a normal driving pressure. This
finding indicates that a significant fraction of the ische-
mic myocardium was excluded from perfusion and thus
from tracer handling before revascularization. Accord-
ingly, it seems conceivable that, at least in some in-
stances, diffusible tracers might overestimate myocardial
blood flow because of underestimation of myocardial
mass, whereas they could underestimate the improve-
ment in blood flow induced by revascularization be-
cause of the increase in perfused mass induced by the
increase in driving coronary pressure.
Finally, these data point out the relevance of perfu-
sion pressure as a primary determinant of the regula-
tion of myocardial blood flow in the myocardium sup-
plied by a severely stenotic coronary artery under
resting conditions. The early beneficial effect of revas-
cularization on blood flow regulation might reflect the
increase in driving coronary pressure. Actually, this
mechanism might also retain a potential relevance in
the precipitation of acute ischemia, thus justifying the
finding of a paradoxical vasoconstrictor response to
increasing myocardial metabolic demand (38). Meth-
ods able to verify such a possibility might help more
accurately characterize the pathogenesis of ischemia in
patients with coronary artery disease.
Limitations. The increase in coronary blood flow ob-
served after angioplasty might reflect the disappear-
ance of collateral circulation. In this instance, actual
perfusion rate to the myocardium might have been less
modified by coronary angioplasty, thus causing the
relative reduction in mean transit time. However, pa-
tients with angiographic evidence of collaterals were
excluded from the present study. Moreover, coronary
wedge pressure was remarkably low in all patients,
and no correlation was observed between this variable
and changes in coronary blood flow and perfused vol-
ume. Coronary pressure measured during balloon oc-
clusion is considered the most accurate clinical descrip-
tor of collateral feeding to the ischemic vascular bed
(36). Thus these observations imply that collaterals
were not extensively developed in these patients and
that the observed increase in coronary blood flow was
not closely related to their presence.
Xe washout was not monitored after adenosine ad-
ministration because of the problems in maintaining
stable levels of coronary blood flow, coronary pressure,
and heart rate during adenosine infusion for the dura-
tion of Xe washout. Accordingly, the present study does
not elucidate the behavior of perfused myocardial vol-
ume under pharmacological vasodilation and at low
perfusion pressure. An increase in perfused mass, un-
der vasodilation, might have further confirmed the
hypothesis of the active nature of the heterogeneous
vasoconstriction.
Coronary blood flow was not monitored in the con-
tralateral region. This evaluation might have allowed a
more precise definition of perfused volume in a myo-
cardium not subjected to changes in perfusion pres-
sure, at least in the large arterial system. However,
placing a further instrument in an untreated coronary
artery was considered unethical in patients with coro-
nary artery diseases underlying a study during coro-
nary angioplasty.
Utilization of the gamma-camera allowed accurate
myocardial imaging, with clear separation between
regions supplied by the stenotic or nonstenotic vessels.
However, an exact definition of possible regional dif-
ferences within the region supplied by the left anterior
descending coronary artery could not be identified with
the planar imaging method adopted. Moreover, be-
cause of the limited spatial resolution of the method, no
conclusion can be drawn about the distribution of flow
heterogeneity or the individual size of hypoperfused or
normally perfused myocardial units. These limitations,
together with the limited patient population, prevent
an accurate definition of the shape of the relationship
between coronary pressure and perfused myocardial
mass as well as the temporal variability of myocardial
perfusion.
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